Table 2. Clinical characteristics and outcomes of patients infected with CRKP.
Characteristics | No./total (%) |
---|---|
Infection types | |
Intra-abdominal infection | 18/252 (7.14) |
Urinary tract infection | 30/252 (11.90) |
Lower respiratory tract infection | 209/252 (82.94) |
Bacteremia | 23/252 (9.13) |
Meningitis | 25/252 (9.92) |
Other infections | 3/252 (1.19) |
APACHE II Score | 20 (4~48) |
Septic shock | 3/252 (1.19) |
Laboratory findings | |
White blood cell, /mm3 | |
Median (Interquartile range) | 13.82 (3.6~88.8) |
Subgroup | |
<4,000 (/mm3) | 30/252 (11.90) |
>10,000 (/mm3) | 151/252 (59.92) |
C-reactive protein >10 mg/L | 118/252 (46.82) |
Procalcitonin | |
>2 ng/mL | 40/252 (15.87) |
Clinical outcomes | |
Length of stay, median (interquartile range), days | 37.11 (3~730) |
ICU admission | 204/252 (80.95) |
Length of ICU stay, median (interquartile range), days | 14.44 (1~112) |
Discharge disposition | |
Home | 127/252 (50.540) |
Long-term acute facility | 3/252 (1.19) |
Follow-up outpatient | 15/252 (5.95) |
Transfer to other hospitals | 11/252 (4.37) |
Mortality | |
In-hospital mortality | 59/252 (23.41) |
30 day’s mortality | 37/252 (14.68) |
CRKP, carbapenem-resistant Klebsiella pneumoniae.